James A. Singleton

TL;DR: For example, this article used data from the 2017 National Immunization Survey-Child (NIS-Child) to assess vaccination coverage at national, state, territorial, and selected local levels among children aged 19-35 months in the United States.

TL;DR: The burden of seasonal influenza in the United States, focused mainly on influenza‐related mortality and hospitalization, was generated every few years and expanded to include estimates of influenza‐ related outpatient medical visits and symptomatic illness in the community.

TL;DR: A concerted effort to increase provider adoption of standards for adult immunization, public awareness, and stable vaccine supplies is needed to improve influenza vaccination rates among recommended groups, and to reduce racial and ethnic disparities.

TL;DR: The adverse event profile after2009-H1N1 vaccine in VAERS was consistent with that of seasonal influenza vaccines, although the reporting rate was higher after 2009-H 1N1 than seasonal influenza vaccine, this may be, at least in part, a reflection of stimulated reporting.

TL;DR: Now that an ample supply of 2009 H1N1 vaccine is available, efforts should continue to increase vaccination coverage among persons in the initial target groups and to offer vaccination to the rest of the U.S. population, including those aged >or=65 years.